Physician profile
James L Comerci
NPI 1376537191
$1,722.78
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,120 · 2020: $201 · 2021: $229 · 2023: $156 · 2024: $16.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $611.73 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $227.16 | 2019 | |
| Merck Sharp & Dohme LLC | $171.44 | 2019-2020 | |
| Lilly USA, LLC | $102.81 | 2019-2024 | Mounjaro, Zepbound |
| Boston Scientific Corporation | $97.74 | 2023 | Watchman Access System |
| Pfizer INC. | $91.91 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $65.02 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $57.85 | 2019 | |
| Avanir Pharmaceuticals, INC. | $55.13 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $46.84 | 2019-2023 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $39.36 | 2019-2020 | |
| Daiichi Sankyo INC. | $36.09 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.56 | 2019 | |
| Amarin Pharma, INC. | $19.02 | 2019 | |
| Shire North American Group INC | $16.74 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.56 | 2019 | |
| Glaxosmithkline, LLC. | $14.16 | 2019 | |
| Alkermes, INC. | $11.73 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Comerci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.